Umoja Biopharma, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2021-06-24. The offering totals $210.0M, of which $210.0M was reported sold. Industry: Biotechnology.
| Name | Role | Location |
|---|---|---|
| Luke S Evnin | Director | Seattle, WA |
| Anna S French | Director | Seattle, WA |
| Robert S Glassman | Director | Seattle, WA |
| John S Hamer | Director | Seattle, WA |
| Philip S Low | Director | Seattle, WA |
| Andrew M Scharenberg | Director | Seattle, WA |
| Irena M Melnikova | Executive Officer | Seattle, WA |
| Andrew M Scharenberg | Executive Officer | Seattle, WA |